EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metastability as a candidate neuromechanistic biomarker of schizophrenia pathology

Fran Hancock iD, Fernando E Rosas, Robert A McCutcheon, Joana Cabral iD, Ottavia Dipasquale, Federico E Turkheimer

PLOS ONE · 23.03.2023 · 18 (3) · e0282707

DOI: 10.1371/journal.pone.0282707 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 23.03.2023. Verfasst von Fran Hancock und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, London, United Kingdom. Hauptthemen laut MEDLINE: Schizophrenia, Connectome. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 121 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Department of Health, “la Caixa” Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The disconnection hypothesis of schizophrenia proposes that symptoms of the disorder arise as a result of aberrant functional integration between segregated areas of the brain. The concept of metastability characterizes the coexistence of competing tendencies for functional integration and functional segregation in the brain, and is therefore well suited for the study of schizophrenia. In this study, we investigate metastability as a candidate neuromechanistic biomarker of schizophrenia pathology, including a demonstration of reliability and face validity. Group-level discrimination, individual-level classification, pathophysiological relevance, and explanatory power were assessed using two independent case-control studies of schizophrenia, the Human Connectome Project Early Psychosis (HCPEP) study (controls n = 53, non-affective psychosis n = 82) and the Cobre study (controls n = 71, cases n = 59). In this work we extend Leading Eigenvector Dynamic Analysis (LEiDA) to capture specific features of dynamic functional connectivity and then implement a novel approach to estimate metastability. We used non-parametric testing to evaluate group-level differences and a naïve Bayes classifier to discriminate cases from controls. Our results show that our new approach is capable of discriminating cases from controls with elevated effect sizes relative to published literature, reflected in an up to 76% area under the curve (AUC) in out-of-sample classification analyses. Additionally, our new metric showed explanatory power of between 81–92% for measures of integration and segregation. Furthermore, our analyses demonstrated that patients with early psychosis exhibit intermittent disconnectivity of subcortical regions with frontal cortex and cerebellar regions, introducing new insights about the mechanistic bases of these conditions. Overall, these findings demonstrate reliability and face validity of metastability as a candidate neuromechanistic biomarker of schizophrenia pathology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SchizophreniaConnectomeHumansReproducibility of ResultsBayes TheoremMagnetic Resonance ImagingBrainBiomarkers

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Neuroimaging, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, London, United Kingdom.
  • Department of Informatics, University of Sussex, Brighton, United Kingdom.
  • Centre for Psychedelic Research, Department of Brain Science, Imperial College London, London, United Kingdom.
  • Centre for Complexity Science, Imperial College London, London, United Kingdom.
  • Centre for Eudaimonia and Human Flourishing, University of Oxford, Oxford, United Kingdom.
  • Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, De Crespigny Park, London, United Kingdom.

ORCID-Profile: Fran Hancock, Joana Cabral

Förderung

  • Wellcome Trust
  • Department of Health
  • “la Caixa” Foundation
  • Fundação para a Ciência e a Tecnologia
  • National Institute for Health Research (NIHR) Biomedical Research Centre
  • King’s College London

Zitieren

APA

Hancock, F., Rosas, F. E., McCutcheon, R. A., Cabral, J., Dipasquale, O., & Turkheimer, F. E. (2023). Metastability as a candidate neuromechanistic biomarker of schizophrenia pathology. PLOS ONE, 18(3), e0282707. https://doi.org/10.1371/journal.pone.0282707

Vancouver

Hancock F, Rosas FE, McCutcheon RA, Cabral J, Dipasquale O, Turkheimer FE. Metastability as a candidate neuromechanistic biomarker of schizophrenia pathology. PLOS ONE. 2023;18(3):e0282707. doi:10.1371/journal.pone.0282707

BibTeX
@article{Hancock2023,
  author = {Hancock, Fran and Rosas, Fernando E and McCutcheon, Robert A and Cabral, Joana and Dipasquale, Ottavia and Turkheimer, Federico E},
  title = {Metastability as a candidate neuromechanistic biomarker of schizophrenia pathology},
  journal = {PLOS ONE},
  year = {2023},
  volume = {18},
  number = {3},
  pages = {e0282707},
  doi = {10.1371/journal.pone.0282707}
}
Kostenlos starten →